CATX

Perspective Therapeutics Inc

• TipRanks·6d ago

  Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline

• Dow Jones·03/23 11:00

  Perspective Therapeutics Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·03/23 11:00

  Perspective Therapeutics Price Target Raised to $13.00/Share From $12.00 by HC Wainwright & Co.

• TipRanks·03/23 10:16

  Reiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation

• TipRanks·03/23 10:10

  Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright

• TipRanks·03/21 15:00

  Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX)

• TipRanks·03/19 12:28

  Perspective Therapeutics price target raised to $8 from $7 at UBS

• TipRanks·03/18 17:10

  Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Perspective Therapeutics (CATX)

• Dow Jones·03/18 17:00

  Perspective Therapeutics Price Target Raised to $13.00/Share From $11.00 by B. Riley Securities

• Dow Jones·03/18 17:00

  Perspective Therapeutics Is Maintained at Buy by B. Riley Securities

• Benzinga·03/18 16:51

  B. Riley Securities Maintains Buy on Perspective Therapeutics, Raises Price Target to $13

• Dow Jones·03/18 13:27

  Perspective Therapeutics Is Maintained at Buy by UBS

• Benzinga·03/18 13:17

  UBS Maintains Buy on Perspective Therapeutics, Raises Price Target to $8

• TipRanks·03/18 12:51

  Perspective Therapeutics price target raised to $13 from $11 at B. Riley

• Dow Jones·03/18 12:49

  Perspective Therapeutics Price Target Maintained With a $11.00/Share by Wedbush